Vitamin D 2 from irradiated edible mushrooms might present a possible dietary source of this vitamin, subject to its bioavailability. Having previously optimized a method for the conversion of ergosterol in mushrooms to vitamin D 2 , this paper examines the vitamin D-enriched mushrooms (Lentinula edodes) for their bioavailability of the vitamin, using an animal model. Thirty male Wistar rats were fed for 1 week with a diet deficient in vitamin D. After this 1-week period, six rats were randomly selected and killed for analysis of initial bone mineral density, and serum level of 25-hydroxyvitamin D. A group of twelve rats of the test animals received 1 mg of vitamin D 2 from irradiated mushrooms for a period of 4 weeks until being killed. The remaining twelve rats were fed un-irradiated mushrooms at the same level to act as controls. At the end of a 4-week period, the mean serum 25-hydroxyvitamin D level of the experimental group was 129·42 (SD 22·00) nmol/l whereas it was only 6·06 (SD 1·09) nmol/l in the control group. Femur bone mineral density of the experimental group of animals was significantly higher (P,0·01) than the control group. In addition, serum Ca concentrations among groups were shown to be significantly higher (P,0·01). It may be concluded from the results that vitamin D 2 from UV-irradiated mushrooms is well absorbed and metabolized in this model animal system. Significant increase in femur bone mineralization (P,0·01) was shown in the presence of vitamin D 2 from irradiated mushrooms compared with the controls.
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Vitamin D 2 : Ergosterol: Shiitake mushrooms: Bioavailability
In 1919, vitamin D, sometimes referred to as the 'sunshine vitamin' was discovered by Sir Edward Mellanby (Mellanby, 1919) as part of his experiments on rickets. The main role of vitamin D in the body is functioning as a hormone in maintaining Ca homeostasis, important in the mobilization, retention, and bone deposition of Ca and P. Clinically, vitamin D deficiency has been shown to be associated with cancers (Sadava et al. 1996; Platz et al. 2000; Burton, 2001; Hansen et al. 2001; Grant, 2002; Mehta & Mehta, 2002; Polek & Weigel, 2002) , heart diseases (Williams & Lloyd, 1989; Mancini et al. 1996; Norman et al. 2002; Zittermann et al. 2003) , obesity (Heldenberg et al. 1992; Cantorna, 2000; Speer et al. 2001) , diabetes (Billaudel et al. 1998; Bourlon et al. 1999; Hypponen et al. 2001) , and arthritis (McAlindon & Felson, 1996; Braun & Tucker, 1997) . In addition, Vitamin D has been suggested for therapeutic applications in the treatment of several diseases including hyperproliferative diseases, secondary hyperparathyroidism, post-transplant survival, and various malignancies (Peleg, 1997) .
Vitamin D deficiency disorders are common all over the world (Diamond et al. 2000; Ravinder et al. 2000; Semba et al. 2000; Yan et al. 2000; Vieth et al. 2001) . Vitamin D deficiency is an unrecognized epidemic among the elderly population and more than 50 % of elderly persons, living in their own homes and nursing homes in the USA, are reported as deficient in vitamin D (Holick, 2001) . Hence, the introduction of an alternative dietary source of vitamin D would most likely be helpful in protecting this population from such a deficiency. Naturally, wild mushrooms contain only small amounts of vitamin D 2 but are abundant in ergosterol (Mau et al. 1998; Mattila et al. 2002) . Mushrooms are considered a delicacy, highly accepted by vegetarians as well as non-vegetarians, and could be used to supplement vitamin D 2 content in the diets of those populations at risk of vitamin D deficiency.
In a previous study (Perera et al. 2003; Jasinghe & Perera, 2005) , it was shown that UV-B irradiation of cultivated mushrooms gave rise to remarkable amounts of vitamin D 2 . However, use of this information in introducing cultivated mushrooms as an alternative to vitamin D supplement must be subject to the investigation of bioavailability of vitamin D 2 from the irradiated mushrooms.
There are few studies on the bioavailability of vitamin D. However, most of the studies have been carried out using supplements. The absorption of vitamin D from supplements in humans is estimated at about 55 -99 % and the values from food sources are probably lower (Van-den-Berg, 1997). The biologically active metabolite of vitamin D 2 is 25-hydroxyvitamin D 2 (Suda et al. 1969) , and measurement of this compound is considered to be the best indicator of vitamin D status (Holick et al. 1986 ). Furthermore, 25-hydroxyvitamin D, which is the major circulating form of vitamin D, is more suitable as an index of vitamin D status than 1,25-dihydroxyvitamin D, since the half-life of 25-hydroxyvitamin D is more than 7 d and it is circulated in the body at a concentration some 1000 times more than 1,25-dihydroxyvitamin D (Holick, 2004) . Therefore, serum levels of 25-hydroxyvitamin D may be used as a sensitive indicator in the investigation of bioavailability of vitamin D 2 in in vivo studies. In addition, vitamin D deficiency is also associated with bone loss and incidence of fractures (Parfitt et al. 1982; Lips & Obrant 1991; Dawson-Hughes et al. 1995) and therefore measurement of bone mineral density (BMD) could also be used to evaluate vitamin D deficiency status.
Except for one human bioassay (Outila et al. 1999 ), there appears to be no reported data on bioavailability of vitamin D 2 from natural food sources. Hence the focus of this study was to investigate the bioavailability of vitamin D 2 from irradiated edible mushrooms in order to understand its biological activity and the possibility of using this food source to help in eradication of vitamin D deficiency from affected or at-risk populations.
Materials and methods

Animal model
All the procedures were performed according to an approved project protocol, which complied with the Singapore Agri-Food and Veterinary Authority (AVA) regulations, and abided with National Advisory Committee for Laboratory Animal Research (NACLAR), by the laboratory animal centre of the National University of Singapore.
Thirty male Wistar rats (average weight 54·32^5·12 g) were obtained from the laboratory animal-breeding centre, National University of Singapore. All the rats were housed in individual plastic cages at 258C under incandescent lighting. Initially, all the rats were given a diet deficient in vitamin D with 0·47 % Ca and 0·3 % P (Diet TD89123, Teklad Premier Laboratory Diets, Madison, WI, USA) in order to induce vitamin D deficiency. After 1 week, six rats were randomly selected (Group 1), and killed to analyse initial BMD and serum levels of 25-hydroxyvitamin D. A group of twelve rats (Group 2) were administered a known amount (28 mg) of lyophilized, powdered, irradiated Shiitake mushrooms, containing 1 mg vitamin D 2 /d, while the control group (Group 3) received the same amount of non-irradiated Shiitake mushrooms, confirmed to be absent of vitamin D 2 . During the irradiation, each side (caps and gills) of the Shiitake mushrooms was irradiated with UV-B (UV-B Model UVM-57; UVP Inc., Upland, CA, USA) for 1 h. Mushrooms were placed in an irradiation chamber at a distance 15 cm away from the source of UV-B while irradiation was performed at ambient temperature (278C). The calculated irradiation dose after a 2 h period of irradiation (1 h each side) was 35·3 kJ/m 2 . The test diets (28 mg freeze-dried, irradiated and non-irradiated mushroom powder) were administered in liquid form (suspended in 0·5 ml deionized water) directly into their stomachs through a gavage tube, while both groups were given free access to deionized water and the vitamin D-deficient diet. The daily dietary intake and the weight gain were measured using an electronic analytical balance, and at the end of the 4-week period, all the rats were killed for analysis of femur BMD and level of serum 25-hydroxyvitamin D.
Measurements of 25-hydroxyvitamin D 2 , serum calcium and bone mineral density
Serum 25-hydroxyvitamin D was analysed at the Singapore National University Hospital using a Gamma-B 25-hydroxyvitamin D 125 I RIA kit (DiaSorin and IDS Ltd, Boldon, UK) as directed by the manufacturer's product guidelines. This RIA method does not discriminate between 25-hydroxyvitamin D 2 and 25-hydroxyvitamin D 3 . Serum 25-hydroxyvitamin D-bound radioactivity was measured by a gamma well-counting system (Berthold DPC Gamma-C12 multi crystal gamma counter, Berthold, Wilberg, Germany). Serum Ca levels were measured at the Singapore National University Hospital using an automated VITROS 950 chemistry system (Ortho-Clinical Diagnostics, Inc., Raritan, NJ, USA). The BMD of femur bones and the lengths of femur bones were measured at the Singapore National University Hospital with a Lunar DPX-L Dual-Energy X-ray Bone Densitometer, software version 1.3 (Lunar DPX-L, Lunar Corp., Madison, WI, USA).
Statistical analysis
The evaluation of equality of means was carried out by the oneway ANOVA using the F distribution to assess significance (VassarStats, http://vassun.vassar.edu/,lowry/VassarStats.html). The data are expressed as means with their standard deviations.
Results
All the subjects survived until they were killed at the end of the study and neither physiological nor behavioural abnormalities were observed in any group. The ranges of measurements are tabulated in Table 1 .
The body weights at the beginning and end of the study did not differ among groups (P,0·01). Furthermore, the lengths of femur bones did not differ among groups. No significant difference (P,0·01) was shown in daily dietary intakes of Groups 2 and 3. Group 1 was used to evaluate the vitamin D deficiency status * Group 1 on vitamin D-deficient diet for 1 week. Measurements after 1 week, n 6. † Group 2 on vitamin D-deficient diet for 1 week and then irradiated mushrooms þ vitamin D-deficient diet for 4 weeks. Measurements after 5 weeks, n 12. ‡ Group 3 on vitamin D-deficient diet for 1 week, and then non-irradiated mushrooms þ vitamin D-deficient diet for 4 weeks. Measurements after 5 weeks, n 12.
of animals before the administration of test diets. Figure 1 illustrates femur BMD of the three different groups. Femur BMD of Group 2 was significantly higher (P,0·01) than that of the other two groups. The difference in BMD between Group 1 and Group 3 was shown to be not significant (P¼ 0·332). In addition, the BMD values of right and left femurs within the groups were similar and the difference between values was shown not to be significant (Group 1, P¼1·00; Group 2, P¼0·434; Group 3; P¼0·487). Serum 25-hydroxyvitamin D and Ca concentrations of the groups are shown in Table 2 .
The results show that serum 25-hydroxyvitamin D concentration of Group 2 clearly differs from that of Groups 1 and 3. The serum 25-hydroxyvitamin D concentration of Group 2, which received 1 mg vitamin D 2 daily from mushrooms for 4 weeks, was 129·42 (SD 22·00) nmol/l whereas it was only 6·06 (SD 1·09) nmol/l in Group 3, which received no vitamin D 2 . A decrease in 25-hydroxyvitamin D concentration was observed in Group 3 compared with Group 1 but, on the other hand, a remarkable increase was observed in Group 2. The serum Ca levels among groups were also significantly different. In contrast to what might have been expected, the serum Ca level of Group 2 was significantly lower compared with Group 1. This could be due to a higher rate of bone mineralization in Group 2 (which received vitamin D 2 from mushrooms) compared with Group 1. This is supported by the observation that there was a significantly higher BMD and lengths of femur bones in Group 2. In addition, lowered serum levels of parathyroid hormone, raised serum ionized Ca levels and an age-related decline in duodenal Ca absorption have all been reported, and could be contributing factors to this difference (Liang et al. 1989; Takamoto et al. 1990; Agnusdei et al. 1998; Schulz & Morris, 1999) .
Discussion
Bioavailability has been defined as 'that fraction of an oral dose (parent compound or active metabolite) from a particular preparation that reaches the systemic circulation' (Schumann et al. 1997) . The serum concentration of 25-hydroxyvitamin D is the barometer of vitamin D status (Holick, 2001) , and therefore this measurement can be used in bioavailability studies of vitamin D.
In this study, the difference in daily dietary intake of Groups 2 and 3 was shown to be not significant (P¼ 0·853). Assuming only vitamin D 2 was formed in mushrooms under UV radiation, Group 2 received 1 mg of vitamin D 2 from irradiated mushrooms while Group 3 received a similar diet but lacking the vitamin D 2 . Since the animals were housed under incandescent light, cutaneous synthesis of vitamin D was not expected to interfere with the results.
The current results clearly indicate that vitamin D 2 from irradiated mushrooms was well absorbed in the laboratory rats since the serum concentration of 25-hydroxyvitamin D of the experimental group was remarkably higher than the control group. Vieth & Milojevic (1995) reported a value of 58 (SD 8) nmol/l 25-hydroxyvitamin D in a similar rat study using vitamin D 3 as a supplement. In this study, the quantities of vitamin D administered were considerably higher than the amount of vitamin D given there, and this may be the reason for the observation of high values of serum 25-hydroxyvitamin D in this study. The results of this study show dramatic increases in serum 25-hydroxyvitamin D in rats fed with vitamin D 2 from irradiated mushrooms compared with the values reported by Outila et al. (1999) in a human study.
Since vitamin D influences several steps in the active Ca transport system (Bronner, 1987 (Bronner, , 1992 Gueguen & Pointillart, 2000) , measurement of serum Ca concentration is a useful tool to predict vitamin D deficiency. Serum Ca concentration of Group 2 was significantly higher than that of the value for Group 3. Thus, it was clearly indicated that Group 3, fed only on vitamin Ddeficient diet, was indeed deficient in vitamin D.
The dual-energy X-ray bone densitometer is a useful tool for measuring intact and excised rat leg BM (Nagy et al. 2001) . In this study, it was shown that vitamin D 2 from irradiated mushrooms increased femur BMD of laboratory rats. Since vitamin D is directly involved in bone mineralization (Schapira et al. 1995; Erben et al. 1997 Erben et al. , 1998 Erben et al. , 2002 Kaastad et al. 2001) , the results of the current study show that in laboratory rats, vitamin D 2 from irradiated edible mushrooms has an important positive effect on the femur bone mineralization, especially during the period that the rats lay down their skeleton. In conclusion, vitamin D 2 from irradiated edible mushrooms is well absorbed, metabolized to 25-hydroxyvitamin D 2 , and possesses an active role in bone mineralization in animals. The dose of vitamin D 2 for rats, which was used in this study, was about 3 mg/kg body weight. If this dose is converted to an average body weight of a human (70 kg), it is about 200 mg/d. This is approximatly 20 times higher compared with the current RDA of vitamin D for adults (10 mg/d), which some workers believe to be inadequate (Hanly et al. 1985; McKenna et al. 1985 McKenna et al. , 1995 Chapuy et al. 1997; McKenna & Freaney, 1998; Compston, 1998; Cheetham, 1999; Vieth, 1999 Vieth, , 2000 Heaney, 2000) , and even up to 100 mg vitamin D 3 /d is a safe intake (Vieth et al. 2001) . Irradiated edible mushroom powder could be used in the fortification of human food supplements or fresh irradiated mushrooms could be used for human consumption. However, the optimal therapeutic dosage of vitamin, and the effect of its administration on the other animal organs, especially the liver, heart and kidney, hypercalcaemic effect, and the systemic metabolism to its active analogues, have yet to be elucidated. 
